[Hypertension therapy during pregnancy and lactation (author's transl)].
Hypertension in pregnancy is not only of importance to the mother, for whom there is an increased risk of cardiovascular damage, but also for the unborn child because it leads to a reduction of blood flow in the uteroplacental unit and consequently to a disturbance of growth and maturation. Reduction of blood pressure by drugs lowers the incidence of cardiovascular diseases in the mother in the same way as outside pregnancy. There is, however, a well-founded suspicion that the blood flow in the uteroplacental unit may be still further reduced by some antihypertensives, at least in certain situations. Therefore careful consideration must be given to which antihypertensives can be used during pregnancy and which cannot.
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D004232:Diuretics / Q000627:therapeutic use; D004461:Eclampsia / Q000175:diagnosis; D005260:Female; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000175:diagnosis / Q000188:drug therapy*; D007774:Lactation / Q000187:drug effects; D008431:Maternal-Fetal Exchange / Q000187:drug effects; D011225:Pre-Eclampsia / Q000175:diagnosis; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular / Q000188:drug therapy*; D011379:Prognosis
D000319:Adrenergic beta-Antagonists; D000959:Antihypertensive Agents; D004232:Diuretics
Hochdrucktherapie während Schwangerschaft und Stillperiode.